Almac, Pfizer reveal steps to slash gene therapy labeling times
Almac outlines work with Pfizer to quickly get patient-specific gene therapies to DMD patients.
Archives for February 12, 2020
Novo Nordisk continues ‘investment year’ with expansion of production
The company announces the injection of DKK 800m into the Kalundborg facilities responsible for producing its diabetes treatments.
Merck to focus on Keytruda, separating out biosimilar business
The newly separate business will include women’s health, legacy brands, and biosimilar units, as the main part of the business retains oncology, vaccines, hospital and animal health.
Biogen prepares to step up manufacturing to support Alzheimer's launch
Biogen readies manufacturing operation to meet anticipated “large demand” for Alzheimer’s disease drug.